'Bladder cancer has had its share of headlines recently. Not because the public is uninformed about the disease or because scientists discovered a new wonder drug targeting bladder cancer cells. Rather, the disease keeps on reappearing under the adverse side effects category for one diabetes drug -- Actos.
We all know that diabetes has its own sets of health challenges, and to be bombarded by studies confirming a diabetes drug's bladder cancer risk brings chills to type 2 patients and their families.
But the truth is that Actos (known generically as pioglitazone) has been repeatedly linked to bladder cancer.'
Read more...
Related Post:
Widget by [ Iptek-4u ]
